共 50 条
- [41] EVALUATION OF PROLONGED INDOMETHACIN TREATMENT IN PRETERM INFANTS WITH SYMPTOMATIC PATENT DUCTUS-ARTERIOSUS ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1986, 59 : 152 - 152
- [42] Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (02):
- [43] Predictors of a non-response to prophylactic indomethacin for patent ductus arteriosus in preterm infants PEDIATRICS AND NEONATOLOGY, 2023, 64 (04): : 398 - 404
- [45] INDOMETHACIN THERAPY IN PREMATURE-INFANTS WITH PATENT DUCTUS-ARTERIOSUS AND OLIGURIA DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS, 1986, 9 (06): : 369 - 374
- [46] INDOMETHACIN THERAPY IN INFANTS WITH ADVANCED POSTNATAL AGE AND PATENT DUCTUS-ARTERIOSUS CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1986, 9 (04): : 250 - 253
- [47] CHANGES IN CEREBRAL HEMODYNAMICS IN PRETERM INFANTS WITH AND WITHOUT PATENT DUCTUS-ARTERIOSUS ACTA PAEDIATRICA SCANDINAVICA, 1983, : 23 - 27
- [48] DIMINISHED CEREBRAL PERFUSION IN PRETERM INFANTS WITH A LARGE PATENT DUCTUS-ARTERIOSUS CLINICAL RESEARCH, 1982, 30 (01): : A145 - A145
- [49] Cerebral oxygenation and echocardiographic parameters in preterm neonates with a patent ductus arteriosus: an observational study ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2016, 101 (06): : F520 - F526
- [50] Isoprostanes as Biomarker for Patent Ductus Arteriosus in Preterm Infants FRONTIERS IN PEDIATRICS, 2020, 8